Topical delgocitinib in severe chronic hand eczema: an alternative to systemic therapy with practical considerations and economic impact
Clinical and Experimental Dermatology · 17.08.2026 · 51 (9) · 1761-1762
DOI: 10.1093/ced/llag212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 17.08.2026. Verfasst von Emily House und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Homerton Healthcare NHS Foundation Trust, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Chronic hand eczema can cause major functional and occupational impairment and may be difficult to manage when systemic therapies are contraindicated. We report the use of topical delgocitinib in severe, treatment-refractory disease, demonstrating rapid clinical improvement, return to work and reduced monitoring burden compared with systemic therapy. This case series experience supports topical delgocitinib as an effective and practical therapeutic option in selected patients.
Autor:innen und Institutionen
- Department of Dermatology, Homerton Healthcare NHS Foundation Trust, London, UK.
Zitieren
APA
House, E., & Chapman, A. B. (2026). Topical delgocitinib in severe chronic hand eczema: an alternative to systemic therapy with practical considerations and economic impact. Clinical and Experimental Dermatology, 51(9), 1761-1762. https://doi.org/10.1093/ced/llag212
Vancouver
House E, Chapman AB. Topical delgocitinib in severe chronic hand eczema: an alternative to systemic therapy with practical considerations and economic impact. Clinical and Experimental Dermatology. 2026;51(9):1761-1762. doi:10.1093/ced/llag212
BibTeX
@article{House2026,
author = {House, Emily and Chapman, Anna B},
title = {Topical delgocitinib in severe chronic hand eczema: an alternative to systemic therapy with practical considerations and economic impact},
journal = {Clinical and Experimental Dermatology},
year = {2026},
volume = {51},
number = {9},
pages = {1761--1762},
doi = {10.1093/ced/llag212}
}
EUVIMED